Finwire Media publishes presentation of NanoEcho ahead of IPO

Ahead of the upcoming stock exchange listing, Finwire Media has published a presentation where our CEO, Linda Persson, discusses NanoEcho’s technology with the aim of improving the diagnosis of rectal cancer and creating significant health-economic benefits for society. Linda also shares her insights on the company’s strategy to get the system approved and implemented as a standard in healthcare.

Watch the full presentation here:

More information about the ongoing share issue and how you can participate is available on our website:

Pågående emission
i NanoEcho

Erbjudande om att teckna aktier i NanoEcho AB (publ) i samband med IPO
Teckningstid: 29 maj – 28 juni

We use cookies to enhance your experience on our website and analyze our traffic. By clicking ‘Accept,’ you consent to our use of cookies. You can learn more about the types of cookies we use and how to manage them in our privacy policy.